(ZALT) Innovator U.S. Equity 10 - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Defined Outcome
ZALT: Options, ETFs, Stocks
The Innovator U.S. Equity 10 Buffer ETF - Quarterly (BATS:ZALT) is designed to provide investors with exposure to the S&P 500 while incorporating a buffer against potential losses. The fund achieves this by investing at least 80% of its net assets in FLEX Options, which are customizable exchange-traded options contracts referencing the SPDR S&P 500 ETF Trust. These options allow the fund to seek a defined outcome, specifically a 10% buffer against the first 10% of losses over a quarterly outcome period. The fund is managed by Innovator Capital Management, a pioneer in defined outcome ETFs, and is classified as a non-diversified investment vehicle, meaning it can concentrate its holdings in a limited number of securities or strategies. This structure is particularly appealing to risk-averse investors seeking equity exposure with built-in downside protection.
From a technical perspective, ZALT has shown a stable trading pattern, with its 20-day moving average (30.25) slightly above its 50-day moving average (30.11) and both above its 200-day moving average (29.13). The Average True Range (ATR) of 0.15 indicates low volatility, suggesting that price fluctuations are likely to remain subdued. The funds assets under management (AUM) of $385.13 million reflect moderate investor interest, with an average daily trading volume of 116,555 shares. Over the next three months, ZALT is expected to maintain its current trading range, with potential for slight upside if broader market conditions remain favorable. The funds price stability, combined with its defined outcome strategy, positions it as a defensive equity play in uncertain markets.
Additional Sources for ZALT ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ZALT ETF Overview
Market Cap in USD | 401m |
Category | Defined Outcome |
TER | 0.69% |
IPO / Inception | 2023-09-29 |
ZALT ETF Ratings
Growth 5y | 53.4% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -1.01 |
Analysts | - |
Fair Price Momentum | 28.20 USD |
Fair Price DCF | - |
ZALT Dividends
No Dividends PaidZALT Growth Ratios
Growth Correlation 3m | 20.8% |
Growth Correlation 12m | 96.7% |
Growth Correlation 5y | 98.6% |
CAGR 5y | 10.70% |
CAGR/Max DD 5y | 3.26 |
Sharpe Ratio 12m | 2.42 |
Alpha | 2.35 |
Beta | 0.35 |
Volatility | 7.87% |
Current Volume | 365.1k |
Average Volume 20d | 95.7k |
As of March 14, 2025, the stock is trading at USD 29.62 with a total of 365,134 shares traded.
Over the past week, the price has changed by -1.33%, over one month by -2.02%, over three months by -1.53% and over the past year by +8.42%.
Partly, yes. Based on ValueRay Analyses, Innovator U.S. Equity 10 (BATS:ZALT) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 53.38 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ZALT as of March 2025 is 28.20. This means that ZALT is currently overvalued and has a potential downside of -4.79%.
Innovator U.S. Equity 10 has no consensus analysts rating.
According to ValueRays Forecast Model, ZALT Innovator U.S. Equity 10 will be worth about 30.8 in March 2026. The stock is currently trading at 29.62. This means that the stock has a potential upside of +4.02%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 30.8 | 4% |